Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPF
Clinical trial NCT06181370 · COMPLETED
Trial details
- NCT number
- NCT06181370
- Sponsor
- Agomab Spain S.L.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2026-04-29
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.